To include your compound in the COVID-19 Resource Center, submit it here.

Agile gets second CRL for Twirla

Agile Therapeutics Inc. (NASDAQ:AGRX) was off $2.24 (47%) to

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE